Fourth Circuit Says Walgreens Must Face FCA Action over Hepatitis C Drugs
- August 18, 2023
The Fourth Circuit revived August 15 a False Claims Act (FCA) lawsuit against Walgreen Co. alleging one of its pharmacies defrauded the Virginia Medicaid program by submitting claims for hepatitis C drugs of patients who were ineligible for the pricey medications.
ARTICLE TAGS
You must be logged in to access this content.